RhumbLine Advisers
VINC

RhumbLine Advisers’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

RhumbLine Advisers’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-665
Closed -$53K – 3262
2022
Q1 		$53K Buy
+665
New +$53K ﹤0.01% 2969